NCT00290706 2019-05-28A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's LymphomaNorthwestern UniversityPhase 1/2 Terminated32 enrolled 12 charts
NCT00096005 2014-02-24Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Terminated36 enrolled
NCT00103272 2013-06-0417-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic CancerNational Cancer Institute (NCI)Phase 1 Terminated74 enrolled